Catalyst Wire Dossier Catalyst Wire Dossier

Shuxuetong

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Shuxuetong, covering 2013-05-14 to 2020-07-22. Get the full timeline:

Most recent: Clinical Trial Update: Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism [Phase 4]

See pricing